| Original language | English |
|---|---|
| Pages (from-to) | 8-10 |
| Number of pages | 3 |
| Journal | Journal of Clinical Oncology |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Benzamides
- Gastrointestinal Neoplasms/drug therapy
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
- Piperazines/pharmacology
- Protein-Tyrosine Kinases/adverse effects
- Pyrimidines/pharmacology
Fingerprint
Dive into the research topics of 'Targeted therapy with imatinib: Hits and misses?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver